Form 4 Tracker
Andrew Booth

Chief Financial Officer · 3 filings · Latest: Aug 14, 2026

AbCellera Biologics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ABCL
Andrew BoothChief Financial OfficerAug 14, 2026
Purchase
$10.3237,200$383.9K482,800
ABCL
Andrew BoothChief Financial OfficerJun 3, 2026
Option Exercise
$0.19250,000$47.5K445,600
ABCL
Andrew BoothChief Financial OfficerFeb 27, 2026
Purchase
$3.4242,600$145.7K195,600